NNIT A/S 225 0 Kommentare Financial report for 2022

NNIT set out to enable future growth in 2022 and launched strategic initiatives to unlock the Group’s full business potential as a specialized IT consulting business focused on the two core business areas of Life Sciences Solutions and Cloud & Digital Solutions with a strong and consolidated Global Delivery Center and streamlined operations.

Financial highlights for 2022*

Revenue increased 9.6% (organic growth of -1%) to DKK 1,500 million driven mainly by the impact of the acquisitions of SL Controls in 2021 and prime4services in 2022 as well as positive currency effects.
The operating result before special items was a loss of DKK 7 million compared to a loss of DKK 15 million in 2021 with both financial years being impacted by stranded costs following the carve-out of the infrastructure operations. The operating profit margin was -0.5% before special items against -1.1% in 2021.
Special items amounted to DKK 278 million against DKK 208 million in 2021. The costs related mainly to the relocation of the Delivery Center from China to the Philippines and costs related to the carve-out. In addition, special items include employee benefit costs as part of contingent consideration agreement previously recognized as goodwill and impairment of the headquarter building.

Business highlights

NNIT announced the divestment of its infrastructure operations in June to establish the Group as a highly specialized IT services provider focusing exclusively on Life Sciences Solutions and Cloud & Digital Solutions. Closing is expected in the first half of Q2, 2023.
To boost the Group’s Production IT offering to the life sciences industry, NNIT acquired prime4 services, a leading European Manufacturing Execution System services provider.
NNIT won a range of substantial contracts with ATP, Danmarks Nationalbank, the Danish Health Data Authority, the Agency for Higher Education and Science and Lantmännen Unibake as well as new engagements and renewals with strong traction within Regulatory Affairs, Clinical and Production.
NNIT committed to the Science Based Targets initiative (SBTi) and intends to set both short-term and long-term targets for reduction of CO2 emissions.